Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2010
12/01/2010CN101407810B Small interfering RNA with midkine gene as target, vector and use thereof
12/01/2010CN101402959B Promotor replacement method for improving volume of production of bacillus subtilis surfactin
12/01/2010CN101368218B Primer for broad bean dyeing virus detection
12/01/2010CN101353652B Chaetomium cupreum chitinase ChBD deletion mutant, genes thereof, preparation and used primer
12/01/2010CN101348833B ITS sequence of Tremella aurantiablba Bandoni and Stereum hirsutum and method for identifying golden fungus using the same
12/01/2010CN101328502B Method and reagent box for predicting dihydrochlorothiazide antihypertensive efficacy
12/01/2010CN101323643B Optimized TACI-Fc fuse protein
12/01/2010CN101319219B Method for preparing deoxidized violacein and special recombinant bacterium
12/01/2010CN101298599B Mangrove rhizosphere azotobacter (DZY-N33) and use thereof
12/01/2010CN101280339B SCAR molecular marker capable of identifying sea-tangle female gametophyte
12/01/2010CN101270384B Primer sequence for testing imazalil fastness frequency of fingerlike penicillium notatum and testing method
12/01/2010CN101260403B Plant strong salt-resistant gene AtNHXS1 and its coding protein and application
12/01/2010CN101260371B Genome rearrangement trichoderma and its preparation and application
12/01/2010CN101255436B Food-grade expression method for superoxide dismutase gene and special vectors thereof
12/01/2010CN101245392B Method and reagent kit for forecasting susceptibility of incidence of intracerebral haemorrhage
12/01/2010CN101225441B Method for detecting genetic constitution of clone-specific T lymphocyte TCR BV CDR3
12/01/2010CN101177688B Mutation penicillin G acylase, recombinant expression plasmid and transformation engineering strains thereof
12/01/2010CN101157728B ERK2 combination polypeptide and preparation thereof
12/01/2010CN101153274B Method for improving volume of production of rifamycin
12/01/2010CN101131363B Yeast triple-hybridization based small molecule compound detecting method
12/01/2010CN101065489B Swine vesicular disease virus like particle using genetic engineering and the method for manufacturing thereof
12/01/2010CN101058808B Breast cancer relevant p60 gene, coding protein and application thereof
12/01/2010CN101029314B Corn starch branching enzyme gene sirna expression carrier
11/2010
11/30/2010US7844940 Mask set for microarray, method of fabricating mask set, and method of fabricating microarray using mask set
11/30/2010US7842863 Maize variety PHP8R
11/30/2010US7842861 Soybean variety RJS31002
11/30/2010US7842860 Soybean variety RJS35001
11/30/2010US7842859 Soybean variety XR25F09
11/30/2010US7842858 Soybean variety XB30L09
11/30/2010US7842857 Soybean variety RJS53002
11/30/2010US7842856 Herbicide resistance gene, compositions and methods
11/30/2010US7842855 Expression vector comprising nucleotide sequences coding isomerase for use in generating plants with enhanced isoprenoid biosynthesis
11/30/2010US7842854 Expression vector comprising nucleotide sequences coding polypeptides for generation and propagation of drought, freeze and salt resistant plants
11/30/2010US7842853 Transgenic plants synthesizing high amylose starch
11/30/2010US7842852 Producing oils and/or lipids having high content of polyunsaturated fatty acids containing at least two double bonds in recombinant animals comprising ketoacyl-CoA reductase genes
11/30/2010US7842851 Floral transition genes in maize and uses thereof
11/30/2010US7842799 Plasmid comprising fungal proteolytic enzyme; improving production of foods, pharmaceuticals and detergents
11/30/2010US7842798 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842796 PUFA polyketide synthase systems and uses thereof
11/30/2010US7842792 Compositions and methods for non-targeted activation of endogenous genes
11/30/2010US7842790 Immunoglobulin fusion for use in treating eating disorders associated with tumor growth and therapeutics
11/30/2010US7842788 Metalloproteinase specific immunoglobulin for use in treatment and prevention of degradative diseases of connective tissue
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842786 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
11/30/2010US7842785 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842783 Mouse spermatogenesis genes related to human male sterility
11/30/2010US7842781 purified polynucleotide; genomic mycobacterial DNA libraries in an alternative type of vectors, Bacterial Artificial Chromosome; resulting BAC clones could maintain large mycobacterial DNA inserts; 70% of the clones contained inserts in the size of 25 to 104 kb; probes or primers; stringent hybridization
11/30/2010US7842673 introducing an oligonucleotide into a donor cell, particularly a stem cell, and contacting the target cell with the donor cell under conditions permitting the donor cell to form a gap junction channel composed of connexin 43 with the target cell, thus donor cell delivers oligonucleotide to target cell
11/30/2010US7842503 Hybrid recombinases for genome manipulation
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010US7842497 Production of isoprenoids
11/30/2010US7842493 expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production
11/30/2010US7842492 nucleic acid molecule which codes for 6-O-sulfatase or N-sulfamidase; degrading monosaccharides or polysaccharides with the molecules; degrading glycosaminoglycan
11/30/2010US7842489 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/30/2010US7842488 Polynucleotides encoding a human 3-phosphoinositide- dependent protein kinase
11/30/2010US7842485 modified Escherichia coli (E. coli) microorganism that has been modified to increase the expression of a gene selected from the group consisting of yfdE, yhhL, yhhM whereby an alcohol tolerance is enhanced; for producing ethanol
11/30/2010US7842483 Cytochrome c oxidase enzyme complex
11/30/2010US7842481 Method for producing extra-chromosomal nucleic acid molecules
11/30/2010US7842480 Protein fusion comprising transport domain for use in treatment and prevention of viral inection and cell proliferative disorders
11/30/2010US7842479 mutant bacterial cells having an alteration in the expression or activity of the cidABC operon; identifying agents that increase the susceptibility of bacteria to cell death; drug screening
11/30/2010US7842478 DNA encoding mammalian phosphodiesterases
11/30/2010US7842476 In vitro peptide expression library
11/30/2010US7842457 Bead emulsion nucleic acid amplification
11/30/2010US7842298 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
11/30/2010US7842297 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
11/30/2010US7842296 Sequences from Piscirickettsia salmonis
11/30/2010US7842295 Canine influenza virus and related compositions and methods of use
11/30/2010US7842290 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
11/30/2010US7842289 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/30/2010CA2484871C Novel aldolase and production process of substituted .alpha.-keto acids
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2322202C Detection and characterization of microorganisms
11/30/2010CA2296760C Strong early seed-specific gene regulatory region
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2259595C Dna immunization against chlamydia infection
11/30/2010CA2189740C Transgenic arthritic mice
11/25/2010WO2010135749A1 Herpes simplex virus type2: compositions and methods for eliciting an immune response
11/25/2010WO2010135742A1 Antibiotic-free plasmid
11/25/2010WO2010135728A2 Extracellular plant ferredoxin-like protein and uses thereof
11/25/2010WO2010135714A2 Methods for modulating adipocyte expression using microrna compositions
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135695A2 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
11/25/2010WO2010135655A2 Human skin substitutes expressing il-12
11/25/2010WO2010135585A2 Engineered type iv pilin of clostridium difficile
11/25/2010WO2010135558A1 Systhetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
11/25/2010WO2010135495A2 Stable, spray dried, immunogenic, viral compositions
11/25/2010WO2010135401A2 Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
11/25/2010WO2010135329A2 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
11/25/2010WO2010135222A1 Methods and compositions for selecting an improved plant
11/25/2010WO2010135207A1 Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules
11/25/2010WO2010135054A2 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
11/25/2010WO2010134975A2 Methods for enhancing infectivity of retroviruses
11/25/2010WO2010134850A1 Reagent for determining adenosine-5'-triphosphate
11/25/2010WO2010134814A2 Means and methods for counteracting polyq expansion disorders
11/25/2010WO2010134686A2 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof
11/25/2010WO2010134654A1 Transcription factor ap37 increasing resistance of plants against drought stress, and use thereof
11/25/2010WO2010134588A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
11/25/2010WO2010134526A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
1 ... 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 ... 4023